Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 6 Compare versions History 16 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: Feb 3, 2025
Last action: Apr 1, 2025 — Second Reading referred to Health and Human Services Committee then to Appropriations Committee
Session: 2026
Momentum: 60 · High

PASSAGE PROBABILITY

24.8% Unlikely

Why this number

Stage base Passed First Chamber — base rate 45%, measured from OK's completed sessions
Momentum +2 60/100 from the pace of recorded action
Time since last action -22 560 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.